McKesson reports flat revenues for Medical-Surgical segment Company advanced its spinoff of that segment by implementing transition service agreements
By HME News Staff
Updated 9:38 AM CST, Mon February 9, 2026
IRVING, Texas – McKesson has reported $3 billion in revenues for the third quarter of fiscal year 2026 for its Medical-Surgical Solutions segment, a 1% increase, driven by higher volumes of specialty pharmaceuticals.
For the segment, operating profit was $265 million, and adjusted segment operating profit was $265 million, a 10% decrease, driven by lower volumes across physician office settings and lower incidence of illness for the season.
McKesson reported $106.2 billion in consolidated revenues, an 11% increase.
Other financial results for the overall company:
- Earnings per diluted share of $9.59 increased $2.64.
- Adjusted earnings per diluted share of $9.34 increased 16%.
- $1.2 billion of cash flow from operations and $1.1 billion of free cash flow.
“McKesson delivered another strong quarter, extending the momentum we’ve built across the enterprise and demonstrating the impact of our disciplined execution,” said Brian Tyler, CEO. “Our results highlight the strength of our core distribution businesses and the meaningful progress we are making against our strategic priorities.”
Among the company’s business highlights for the quarter: On Jan. 1, 2026, McKesson advanced its planned separation of the Medical-Surgical Solutions segment by implementing transition service agreements to support the business as it prepares to be an independent company.
McKesson is raising and narrowing its fiscal 2026 adjusted earnings per diluted share guidance to $38.80 to $39.20 from the previous range of $38.35 to $38.85.
Comments